CS
ITCI
Candriam SCA’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-214,320
| Closed | -$17.9M | – | 719 |
|
|
2024
Q4 | $17.9M | Buy |
214,320
+50,188
| +31% | +$4.19M | 0.1% | 182 |
|
|
2024
Q3 | $12M | Buy |
+164,132
| New | +$12M | 0.07% | 248 |
|
|
2022
Q4 | – | Sell |
-35,907
| Closed | -$1.67M | – | 894 |
|
|
2022
Q3 | $1.67M | Hold |
35,907
| – | – | 0.01% | 615 |
|
|
2022
Q2 | $2.05M | Hold |
35,907
| – | – | 0.02% | 502 |
|
|
2022
Q1 | $2.2M | Sell |
35,907
-81,710
| -69% | -$5M | 0.01% | 518 |
|
|
2021
Q4 | $6.16M | Sell |
117,617
-367,849
| -76% | -$19.3M | 0.04% | 318 |
|
|
2021
Q3 | $18.1M | Buy |
485,466
+165,979
| +52% | +$6.19M | 0.12% | 191 |
|
|
2021
Q2 | $13M | Sell |
319,487
-136,535
| -30% | -$5.57M | 0.09% | 246 |
|
|
2021
Q1 | $13.9M | Hold |
456,022
| – | – | 0.12% | 198 |
|
|
2020
Q4 | $14.5M | Buy |
456,022
+26,022
| +6% | +$828K | 0.11% | 200 |
|
|
2020
Q3 | $11M | Sell |
430,000
-140,000
| -25% | -$3.59M | 0.1% | 211 |
|
|
2020
Q2 | $14.6M | Sell |
570,000
-323,000
| -36% | -$8.29M | 0.15% | 165 |
|
|
2020
Q1 | $30M | Hold |
893,000
| – | – | 0.33% | 60 |
|
|
2019
Q4 | $30.6M | Sell |
893,000
-25,000
| -3% | -$858K | 0.33% | 60 |
|
|
2019
Q3 | $6.86M | Buy |
918,000
+400,000
| +77% | +$2.99M | 0.09% | 260 |
|
|
2019
Q2 | $6.69M | Sell |
518,000
-140,000
| -21% | -$1.81M | 0.08% | 265 |
|
|
2019
Q1 | $8.02M | Buy |
658,000
+20,000
| +3% | +$244K | 0.1% | 233 |
|
|
2018
Q4 | $7.27M | Buy |
638,000
+90,000
| +16% | +$1.03M | 0.11% | 216 |
|
|
2018
Q3 | $11.9M | Buy |
548,000
+311,000
| +131% | +$6.75M | 0.16% | 160 |
|
|
2018
Q2 | $4.19M | Buy |
237,000
+19,000
| +9% | +$336K | 0.07% | 332 |
|
|
2018
Q1 | $4.59M | Sell |
218,000
-62,000
| -22% | -$1.31M | 0.08% | 297 |
|
|
2017
Q4 | $4.05M | Buy |
280,000
+103,000
| +58% | +$1.49M | 0.07% | 309 |
|
|
2017
Q3 | $2.79M | Buy |
177,000
+22,000
| +14% | +$347K | 0.05% | 385 |
|
|
2017
Q2 | $1.93M | Sell |
155,000
-37,000
| -19% | -$460K | 0.04% | 472 |
|
|
2017
Q1 | $3.12M | Buy |
192,000
+75,000
| +64% | +$1.22M | 0.06% | 357 |
|
|
2016
Q4 | $1.77M | Buy |
117,000
+7,000
| +6% | +$106K | 0.04% | 392 |
|
|
2016
Q3 | $1.68M | Sell |
110,000
-119,000
| -52% | -$1.81M | 0.04% | 391 |
|
|
2016
Q2 | $8.89M | Buy |
229,000
+95,000
| +71% | +$3.69M | 0.23% | 114 |
|
|
2016
Q1 | $3.71M | Sell |
134,000
-2,200
| -2% | -$60.8K | 0.09% | 234 |
|
|
2015
Q4 | $7.33M | Buy |
136,200
+20,000
| +17% | +$1.08M | 0.2% | 130 |
|
|
2015
Q3 | $4.65M | Sell |
116,200
-55,800
| -32% | -$2.23M | 0.11% | 215 |
|
|
2015
Q2 | $5.5M | Buy |
+172,000
| New | +$5.5M | 0.11% | 224 |
|